| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.00038 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 9.7e-05 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -1.7e-05 | 1 |